Search research articles
Contact Us
Filters
Showing results (201-210 of 291) with videos related to
Page
of 30
Sort By:
Advances in Experimental Medicine and Biology
|
February 26, 2020
Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?
Francisco Fernandez-Gomez, Helene Tran, Claire-Marie Dhaenens, et al.
Journal of Biomedical Science
|
November 1, 2019
The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
Ouada Nebie, David Devos, Valérie Vingtdeux, et al.
Journal of Neuroscience Research
|
December 24, 2024
Dipyridamole Ameliorates Memory Impairment and Increases Hippocampal Calbindin Expression in Niemann Pick C1 Mice
Lucia Gaddini, Valentina Chiodi, Andrea Matteucci, et al.
Journal of Child Neurology
|
December 28, 2019
Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
Mark Mintz, Jesus E Pina-Garza, Steven M Wolf, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy
Andrea Popelová, Veronika Pražienková, Barbora Neprašová, et al.
Epilepsy & Behavior : E&B
|
November 13, 2020
Long-term safety and tolerability of adjunctive eslicarbazepine acetate in children with focal seizures
Raman Sankar, Fenella J Kirkham, Gregory L Holmes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study
David Blum, Emeline Cailliau, Hélène Béhal, et al.
Frontiers in Pharmacology
|
July 16, 2021
A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration
Marie Tautou, Sabiha Eddarkaoui, Florian Descamps, et al.
The Clinical Journal of Pain
|
June 23, 2009
Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials
Michael C Irizarry, David J Webb, Zahid Ali, et al.
Expert Review of Proteomics
|
May 10, 2008
Biochemistry of Tau in Alzheimer's disease and related neurological disorders
Nicolas Sergeant, Alexis Bretteville, Malika Hamdane, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 291) with videos related to
Sort By:
Page
of 30
Advances in Experimental Medicine and Biology
|
February 26, 2020
Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy?
Francisco Fernandez-Gomez, Helene Tran, Claire-Marie Dhaenens, et al.
Journal of Biomedical Science
|
November 1, 2019
The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates
Ouada Nebie, David Devos, Valérie Vingtdeux, et al.
Journal of Neuroscience Research
|
December 24, 2024
Dipyridamole Ameliorates Memory Impairment and Increases Hippocampal Calbindin Expression in Niemann Pick C1 Mice
Lucia Gaddini, Valentina Chiodi, Andrea Matteucci, et al.
Journal of Child Neurology
|
December 28, 2019
Safety and Tolerability of Adjunctive Eslicarbazepine Acetate in Pediatric Patients (Aged 4-17 Years) With Focal Seizures
Mark Mintz, Jesus E Pina-Garza, Steven M Wolf, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2018
Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy
Andrea Popelová, Veronika Pražienková, Barbora Neprašová, et al.
Epilepsy & Behavior : E&B
|
November 13, 2020
Long-term safety and tolerability of adjunctive eslicarbazepine acetate in children with focal seizures
Raman Sankar, Fenella J Kirkham, Gregory L Holmes, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study
David Blum, Emeline Cailliau, Hélène Béhal, et al.
Frontiers in Pharmacology
|
July 16, 2021
A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration
Marie Tautou, Sabiha Eddarkaoui, Florian Descamps, et al.
The Clinical Journal of Pain
|
June 23, 2009
Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trials
Michael C Irizarry, David J Webb, Zahid Ali, et al.
Expert Review of Proteomics
|
May 10, 2008
Biochemistry of Tau in Alzheimer's disease and related neurological disorders
Nicolas Sergeant, Alexis Bretteville, Malika Hamdane, et al.
Page
of 30